Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma
- 31 March 2005
- Vol. 65 (3) , 594-599
- https://doi.org/10.1016/j.urology.2004.10.019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- PPARγ ligand‐induced apoptosis through a p53‐dependent mechanism in human gastric cancer cellsCancer Science, 2003
- Peroxisome proliferator‐activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell linesCancer, 2002
- Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer CellsJournal of Biological Chemistry, 2002
- A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cellsGut, 2002
- Expression of Peroxisome Proliferator-Activated Receptor γ in Renal Cell Carcinoma and Growth Inhibition by Its AgonistsBiochemical and Biophysical Research Communications, 2001
- Peroxisome Proliferator-Activated Receptor γ Induces Pancreatic Cancer Cell ApoptosisBiochemical and Biophysical Research Communications, 2001
- Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in VivoJournal of Biological Chemistry, 1999
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Novel Sequence Determinants in Peroxisome Proliferator SignalingJournal of Biological Chemistry, 1995
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptorsNature, 1992